Article
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis.
COPD - 1 Dec 2005
Shermock Kenneth M, Gildea Thomas R, Singer Mendel, Stoller James K
Abstract excerpt
The objective was to assess the cost-effectiveness of population screening for alpha-1 antitrypsin (AAT) deficiency. The design was a Markov-based decision analytic model. Hypothetical cohorts were analyzed from birth and followed over time until death using Monte Carlo simulation. The following strategies were compared: 1) screen all newborns, 2) screen all 10-year-old children, and 3) do not screen. Screenees...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.